Influenza Challenge Study of VIS410 in Healthy Volunteers

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Influenza

Interventions

DRUG

VIS410

Single fixed IV dose of VIS410

DRUG

Placebo

Single IV dose of placebo

Trial Locations (1)

SGS Life Sciences, Antwerp

All Listed Sponsors

lead

Visterra, Inc.

INDUSTRY

NCT02468115 - Influenza Challenge Study of VIS410 in Healthy Volunteers | Biotech Hunter | Biotech Hunter